SELANK 10MG

SELANK is a synthetic peptide research compound designed for academic and institutional use in controlled laboratory settings. Derived from the neurotrophic factor selenotide, SELANK has been explored in preclinical studies for its potential effects on neuronal growth, synaptic plasticity, and neuroprotective mechanisms. This product is intended exclusively for research purposes and is not approved for therapeutic, diagnostic, or cosmetic applications.

Research Context

Selank, originally discovered in the Central Asian country of Kazakhstan, has been studied in rodent models for its neuroprotective properties. The peptide has demonstrated potential in enhancing cognitive function, reducing neuroinflammation, and supporting synaptic remodeling under specific experimental conditions. Given its structural similarity to endogenous neurotrophic factors, SELANK is often investigated as a tool to elucidate mechanisms underlying neurodegeneration, learning, and memory processes.

Research Overview

SELANK operates through mechanisms hypothesized to involve modulation of neurotrophic signaling pathways, including the activation of brain-derived neurotrophic factor (BDNF) and subsequent downstream effects on neuronal survival and plasticity. Preclinical studies have explored its effects on:

• Synaptic transmission and long-term potentiation (LTP), which are critical for memory formation.
• Neurodegenerative disease models, such as Alzheimer’s and Parkinson’s, where neuroinflammation and synaptic dysfunction are prominent.
• Behavioral assays assessing cognitive performance, including spatial memory and anxiety-like responses.

While early findings are promising, SELANK remains a novel compound with limited clinical data and requires further validation in controlled research environments.

Key Research Focus Areas

• Neuroprotection and Synaptic Plasticity: Investigation into SELANK’s role in preserving neuronal integrity and enhancing synaptic connectivity under stress conditions.
• Neuroinflammation Modulation: Exploration of its potential anti-inflammatory effects in models of chronic neurodegeneration.
• Behavioral and Cognitive Effects: Assessment of cognitive enhancement, memory retention, and adaptive responses in animal studies.
• Mechanistic Biology: Characterization of SELANK’s interaction with intracellular signaling pathways, including those involving MAPK/ERK and PI3K/Akt.
• Comparative Pharmacology: Analysis of SELANK’s pharmacological profile relative to other neurotrophic peptides, such as BDNF or GDNF.

Important Safety and Compliance Information

The administration of SELANK is strictly reserved for research institutions, academic laboratories, and licensed pharmaceutical scientists. This product is not intended for human or animal consumption and should only be handled in accordance with established biosafety protocols. Preclinical studies must adhere to ethical guidelines and regulatory standards governing experimental animal use. Users are advised to consult relevant literature, peer-reviewed journals, and institutional protocols to ensure appropriate experimental design and safety measures.

For research use only. Not for human or animal consumption.